Condition: NSCLC Adenocarcinoma · Gastroesophageal Cancer (GC) · Gastric Adenocarcinoma · Sponsor: IDEAYA Biosciences
This is a multicenter clinical study to evaluate the safety, efficacy, and Pharmacokinetics (PK) of IDE892 as monotherapy and in combination with other agents including IDE397 in participants with methylthioadenosine phosphorylase (MTAP)-deleted advanced solid tumors within indications of interest.
This description comes directly from the study's public registry record.
IDEAYA Clinical Trials · +1 855 433 2246 · IDEAYAClinicalTrials@ideayabio.com
Always discuss trial participation with your own doctor first.
| Providence Medical Foundation | Santa Rosa, California, United States | Recruiting |
| Johns Hopkins Sibley Memorial Hospital | Washington D.C., District of Columbia, United States | Recruiting |
| BRCR Global-Coral Springs | Coral Springs, Florida, United States | Recruiting |
| Sarah Cannon Research Institute at Florida Cancer Specialists | Orlando, Florida, United States | Recruiting |
| Nebraska Cancer Specialists | Omaha, Nebraska, United States | Recruiting |
| START Astera, LLC | East Brunswick, New Jersey, United States | Recruiting |
| Columbia University Irving Medical Center | New York, New York, United States | Recruiting |
| Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University | Philadelphia, Pennsylvania, United States | Recruiting |
| Sarah Cannon Research Institute | Nashville, Tennessee, United States | Recruiting |
| START Dallas Fort Worth | Fort Worth, Texas, United States | Recruiting |
| MD Anderson | Houston, Texas, United States | Recruiting |
| NEXT Oncology Houston | Houston, Texas, United States | Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07277413